Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Sangamo Therapeutics, Inc. | StockGist | StockGist

Companies
SGMO
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings SGMOSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Sangamo Therapeutics, Inc.

Filed Nov 12, 2025

Accepted Nov 11, 2025, 7:00 PM ET

CIK 0001001233

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

SANGAMO THERAPEUTICS, INC

Person Type

IA

CUSIP: 800677106

Recent Filings

Sangamo Therapeutics, Inc.1 weeks ago

Sangamo Therapeutics, Inc.1 weeks ago

Sangamo Therapeutics, Inc.2 months ago

Sangamo Therapeutics, Inc.2 months ago

Sangamo Therapeutics, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice